Helga Schinkel

Dr. Helga Schinkel

Fraunhofer Institute for Molecular Biology and Applie Ecology, Aachen, North Rhine-Westphalia, Germany
orcid
Senior Scientist, Dept Plant Biotechnology at Fraunhofer IME...

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1996 in Oecologia
Verified
Journal Article
Closed access
PDF file
PHPeter Högberg
Peter Högberg
LHLars Högbom
Lars Högbom
Helga SchinkelHelga Schinkel
Helga Schinkel
MHMona Högberg
Mona Högberg
CJChristian Johannisson
Christian Johannisson
HWHåkan Wallmark
Håkan Wallmark

1 August 2001 in Plant Physiology
Verified
Journal Article
Open access
PDF file
BKBarbara Karpinska
Barbara Karpinska
MKMarlene Karlsson
Marlene Karlsson
Helga SchinkelHelga Schinkel
Helga Schinkel
SSSteffen Streller
Steffen Streller
KSKarl-Heinz Süss
Karl-Heinz Süss
GWGunnar Wingsle
Gunnar Wingsle
Several isoforms of superoxide dismutase (SOD) with a high isoelectric point (pI) have been identified by isoelectric focusing chromatography in protein extracts from Scots pine (Pinus sylvestris) needles. One of these isoforms, a CuZn-SOD with a pI of about 10 and thus denoted hipI-SOD, has been isolated and purified to apparent homogeneity. A cDNA encoding the hipI-SOD protein was cloned and sequenced. Northern hybridization of mRNA isolated from different organs and tissues showed that hipI-SOD has a markedly different pattern of expression compared with chloroplastic and cytosolic SOD. Furthermore, the transcript levels of hipI-SOD and cytosolic SOD were found to respond differently to mechanical wounding, treatment with oxidized glutathione, paraquat, and ozone. Immunogold electron microscopy localized the hipI-SOD in the plasma membrane of sieve cells and the Golgi apparatus of albuminous cells. Moreover, high protein density was also detected in extracellular spaces such as secondary cell wall thickenings of the xylem and sclerenchyma and in intercellular spaces of parenchyma cells.

3 July 2012 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
JKJanina Kirchhoff
Janina Kirchhoff
NRNicole Raven
Nicole Raven
ABAlexander Boes
Alexander Boes
JRJean L. Roberts
Jean L. Roberts
SRSean Russell
Sean Russell
SSStefan Schillberg
Stefan Schillberg
Summary: Plant cell suspension cultures can be used for the production of recombinant pharmaceutical proteins, but their potential is limited by modest production levels that may be unstable over long culture periods, reflecting initial culture heterogeneity and subsequent genetic and epigenetic changes. We used flow sorting to generate highly productive monoclonal cell lines from a heterogeneous population of tobacco BY‐2 cells expressing the human antibody M12 by selecting the co‐expressed fluorescent marker protein DsRed located on the same T‐DNA. Separation yielded ∼35% wells containing single protoplasts and ∼15% wells with monoclonal microcolonies that formed within 2 weeks. Thus, enriching the population of fluorescent cells from initially 24% to 90–96% in the six monoclonal lines resulted in an up to 13‐fold increase in M12 production that remained stable for 10–12 months. This is the first straightforward procedure allowing the generation of monoclonal plant cell suspension cultures by flow sorting, greatly increasing the potential of plant cells as an economical platform for the manufacture of recombinant pharmaceutical proteins.

22 February 2005 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
Andreas SchiermeyerAndreas Schiermeyer
Andreas Schiermeyer
Helga SchinkelHelga Schinkel
Helga Schinkel
SAStefanie Apel
Stefanie Apel
RFRainer Fischer
Rainer Fischer
SSStefan Schillberg
Stefan Schillberg

21 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TFTatjana Feller
Tatjana Feller
PTPascal Thom
Pascal Thom
NKNatalie Koch
Natalie Koch
HSHolger Spiegel
Holger Spiegel
OAOtchere Addai-Mensah
Otchere Addai-Mensah
Helga SchinkelHelga Schinkel
Helga Schinkel
Pf38 is a surface protein of the malarial parasite Plasmodium falciparum. In this study, we produced and purified recombinant Pf38 and a fusion protein composed of red fluorescent protein and Pf38 (RFP-Pf38) using a transient expression system in the plant Nicotiana benthamiana. To our knowledge, this is the first description of the production of recombinant Pf38. To verify the quality of the recombinant Pf38, plasma from semi-immune African donors was used to confirm specific binding to Pf38. ELISA measurements revealed that immune responses to Pf38 in this African subset were comparable to reactivities to AMA-1 and MSP119. Pf38 and RFP-Pf38 were successfully used to immunise mice, although titres from these mice were low (on average 1∶11.000 and 1∶39.000, respectively). In immune fluorescence assays, the purified IgG fraction from the sera of immunised mice recognised Pf38 on the surface of schizonts, gametocytes, macrogametes and zygotes, but not sporozoites. Growth inhibition assays using αPf38 antibodies demonstrated strong inhibition (≥60%) of the growth of blood-stage P. falciparum. The development of zygotes was also effectively inhibited by αPf38 antibodies, as determined by the zygote development assay. Collectively, these results suggest that Pf38 is an interesting candidate for the development of a malaria vaccine.

12 December 2006 in The Plant Journal
Verified
Journal Article
Closed access
PDF file
VSVaibhav Srivastava
Vaibhav Srivastava
Helga SchinkelHelga Schinkel
Helga Schinkel
Johanna WitzellJohanna Witzell
Johanna Witzell
MHMagnus Hertzberg
Magnus Hertzberg
MTMikaela Torp
Mikaela Torp
GWGunnar Wingsle
Gunnar Wingsle